Publications
- TRAIL/Apo2L/ supresses growth of primary human leukemia and myelodysplasia progenitors2002 | First Faculty of Medicine
- Angiopoietin-1, angiopoietin-2 and Tie-2 in tumour and non-tumour and non-tumour tisseu during growth of experimental melanoma2001 | First Faculty of Medicine
- In vitro growth suppresion of AML and CML progenitors by recombinant trail (APO2L)2000 | First Faculty of Medicine
- Growth suppression of CFU-GM progenitors by recombinant trail in MDS and myeloid leukemiasPublication without faculty affiliation
- Expression of angiopoietin-1, angiopoietin-2 and TIE-2 in bone marrow and tumor during growth of experimental melanomaPublication without faculty affiliation
- Angiopoietin-1, angiopoietin-2, and Tie-2 in tumour tissues during growth of experimental melanomaPublication without faculty affiliation
- TRAIL/APO2L inhibits myelodysplasia and myeloid leukemia progenitor growth while it does not affect normal progenitors in vitro and normal CD34+ cell repopulation in NOD/SCID micePublication without faculty affiliation
- Trail-induced growth supression of CFU-GM progenitors in myelodysplatic syndrome (MDS) and myeloid leukemiasPublication without faculty affiliation
- Cell Death Signalling Pathways in the Pathogenesis and Therapy of Haematologic Maliggnancies: Overview of Apoptotic Patways2006 | First Faculty of Medicine
- Elevated circulating endothelial membrane microparticles in paroxysmal nocturnal haemoglobinuria2004 | First Faculty of Medicine
Loading network view...